Downstream Efects of Omission of Axillary Surgery in OlderAdults with Early‑Stage H Por Kati Downstream Efects of Omission of Axillary Surgery in OlderAdults with Early‑Stage H Read More »
Second-Line Endocrine Therapy With or Without PalbociclibRechallenge in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–NegativeAdvanced Breast Cancer: PALMIRA Trial Por Kati Second-Line Endocrine Therapy With or Without PalbociclibRechallenge in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–NegativeAdvanced Breast Cancer: PALMIRA Trial Read More »
Postmastectomy Radiation Therapy forIntermediate-Risk Breast Cancer Patients With0-3 Positive Axillary Lymph Nodes: Emulatingthe SUPREMO Trial Using Real-World Data Por Kati Postmastectomy Radiation Therapy forIntermediate-Risk Breast Cancer Patients With0-3 Positive Axillary Lymph Nodes: Emulatingthe SUPREMO Trial Using Real-World Data Read More »
Evaluating the effect of hyperbaric oxygen therapy to treat mastectomy skinflap ischemia in breast reconstruction: A single-institutionretrospective analysis Por Adson Machado Evaluating the effect of hyperbaric oxygen therapy to treat mastectomy skinflap ischemia in breast reconstruction: A single-institutionretrospective analysis Read More »
Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer Por Adson Machado Endocrine Therapy Omission in Estrogen Receptor–Low (1%-10%) Early-Stage Breast Cancer Read More »
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Por Adson Machado Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial Read More »
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer:ASCO Guideline Update Por Adson Machado Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer:ASCO Guideline Update Read More »
Pathological complete response, histologic grade, and level of stromal tumor-infiltrating lymphocytes in ER + HER2- breast cancer Por [email protected] Pathological complete response, histologic grade, and level of stromal tumor-infiltrating lymphocytes in ER + HER2- breast cancer Read More »
Clinical relevance of clinical treatment score post-5 years (CTS5) in HR-positive, HER2-positive breast cancer Por Adson Machado Clinical relevance of clinical treatment score post-5 years (CTS5) in HR-positive, HER2-positive breast cancer Read More »
Sonolysis during carotid endarterectomy randomised controlled trial Por [email protected] Sonolysis during carotid endarterectomy randomised controlled trial Read More »
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer Por [email protected] Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer Read More »
Selective Elimination of Breast Surgery for Invasive Breast Cancer Por [email protected] Selective Elimination of Breast Surgery for Invasive Breast Cancer Read More »